| Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue | Frank Vinluan | 09/09/20 | National |
| Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More | Frank Vinluan | 08/28/20 | National |
| Two Days, Six IPOs, and $1B Raised for Biotech Research & More | Frank Vinluan | 07/17/20 | National |
| From Overseas, Legend Biotech and Calliditas Therapeutics Eye the Nasdaq | Frank Vinluan | 05/15/20 | New York |
| Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) | Frank Vinluan | 04/22/20 | National |
| Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More | Frank Vinluan | 03/27/20 | National |
| Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven | Frank Vinluan | 03/02/20 | San Francisco |
| No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health | Frank Vinluan | 01/02/20 | National |
| Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs | Frank Vinluan | 09/27/19 | Boston |
| Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More | Frank Vinluan | 09/27/19 | National |
| Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More | Frank Vinluan | 05/17/19 | National |
| TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push | Sarah de Crescenzo | 10/19/18 | San Diego |
| Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More | Ben Fidler | 08/04/17 | National |
| With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug | Ben Fidler | 08/01/17 | Boston |
| Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal | Ben Fidler | 06/12/17 | Boston |
| Bio Roundup: NIH Precision Boost, AHCA to Senate, New Drugs & More | Ben Fidler | 05/05/17 | National |
| Seattle Genetics to Resume Leukemia Drug Trials After FDA Lifts Hold | Frank Vinluan | 03/06/17 | Seattle |
| Bellicum, Molecular Templates Granted $32M for Immuno-Oncology Work | David Holley | 11/17/16 | Texas |
| All In One Place: A New Immuno-Oncology Trial Resource | Alex Lash | 10/19/16 | National |
| Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug | Ben Fidler | 09/07/16 | Boston |
| More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV | Ben Fidler | 08/02/16 | Boston |
| Syros Files For IPO to Push “Gene Control” Drugs Through First Trials | Ben Fidler | 06/06/16 | Boston |
| Celator Parlays Leukemia Drug Data into $1.5B Buyout From Jazz Pharma | Ben Fidler | 05/31/16 | New York |
| UW Health Surgeon’s Startup Expanding Software to Monitor Patients | Jeff Buchanan | 05/27/16 | Wisconsin |
| Tech Megatransfer: Merck Pays Harvard $20M For “Accelerated” Cancer Drugs | Ben Fidler | 03/21/16 | Boston |
| East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More | Ben Fidler | 03/17/16 | Boston |
| Stanford Spins Out Immunotherapy Work Funded By CIRM’s Millions | Alex Lash | 02/25/16 | San Francisco |
| East Coast Biotech Roundup: Editas, Checkmate, Ovid & More | Ben Fidler | 08/14/15 | Boston |
| East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More | Ben Fidler | 06/12/15 | Boston |
| Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech | Alex Lash | 04/29/15 | New York |
